Cancer Genetics Inc (CGIX.OQ)

CGIX.OQ on NASDAQ Stock Exchange Capital Market

7.19USD
18 Dec 2014
Price Change (% chg)

-- (--)
Prev Close
$7.19
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
13,650
52-wk High
$20.95
52-wk Low
$4.84

CGIX.OQ

Chart for CGIX.OQ

About

Cancer Genetics, Inc. (CGI) is an early-stage, diagnostic company. The Company focuses on developing and commercializing genomic tests and services to improve the diagnosis, prognosis and response to treatment (theranosis) of cancer. These cancers include hematological, urogenital and human papillomavirus (HPV)-associated... (more)

Overall

Beta: --
Market Cap (Mil.): $69.91
Shares Outstanding (Mil.): 9.72
Dividend: --
Yield (%): --

Financials

  CGIX.OQ Industry Sector
P/E (TTM): -- 26.17 37.24
EPS (TTM): -1.52 -- --
ROI: -53.23 7.74 18.21
ROE: -65.24 12.01 19.11
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks